Havn Life Sciences Stock Performance
| HAVLF Stock | USD 0.01 0.00 0.00% |
HAVN Life holds a performance score of 9 on a scale of zero to a hundred. The firm retains a Market Volatility (i.e., Beta) of -4.04, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning HAVN Life are expected to decrease by larger amounts. On the other hand, during market turmoil, HAVN Life is expected to outperform it. Use HAVN Life Sciences standard deviation, as well as the relationship between the maximum drawdown and day median price , to analyze future returns on HAVN Life Sciences.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in HAVN Life Sciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting essential indicators, HAVN Life reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 9.4 M | |
| Total Cashflows From Investing Activities | -2 M | |
| Free Cash Flow | -8 M |
HAVN |
HAVN Life Relative Risk vs. Return Landscape
If you would invest 0.01 in HAVN Life Sciences on September 2, 2024 and sell it today you would earn a total of 0.51 from holding HAVN Life Sciences or generate 5100.0% return on investment over 90 days. HAVN Life Sciences is currently producing 15.3846% returns and takes up 124.0347% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than HAVN, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
HAVN Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for HAVN Life's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as HAVN Life Sciences, and traders can use it to determine the average amount a HAVN Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.124
| Best Portfolio | Best Equity | HAVLF | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 124.03 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average HAVN Life is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HAVN Life by adding it to a well-diversified portfolio.
HAVN Life Fundamentals Growth
HAVN Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of HAVN Life, and HAVN Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HAVN Pink Sheet performance.
| Return On Equity | -2.39 | |||
| Return On Asset | -0.37 | |||
| Operating Margin | (7.64) % | |||
| Current Valuation | 626.96 K | |||
| Shares Outstanding | 8.47 M | |||
| Price To Book | 0.21 X | |||
| Price To Sales | 0.98 X | |||
| Revenue | 276.47 K | |||
| EBITDA | (21.8 M) | |||
| Cash And Equivalents | 112.42 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 561.84 K | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (7.88 M) | |||
| Earnings Per Share | (0.15) X | |||
| Total Asset | 4.06 M | |||
About HAVN Life Performance
By analyzing HAVN Life's fundamental ratios, stakeholders can gain valuable insights into HAVN Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if HAVN Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if HAVN Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The company was incorporated in 2020 and is headquartered in Richmond, Canada. Havn Life operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about HAVN Life Sciences performance evaluation
Checking the ongoing alerts about HAVN Life for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for HAVN Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| HAVN Life Sciences is way too risky over 90 days horizon | |
| HAVN Life Sciences has some characteristics of a very speculative penny stock | |
| HAVN Life Sciences appears to be risky and price may revert if volatility continues | |
| HAVN Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| HAVN Life Sciences has accumulated 561.84 K in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. HAVN Life Sciences has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist HAVN Life until it has trouble settling it off, either with new capital or with free cash flow. So, HAVN Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HAVN Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HAVN to invest in growth at high rates of return. When we think about HAVN Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 276.47 K. Net Loss for the year was (22.44 M) with profit before overhead, payroll, taxes, and interest of 89.69 K. | |
| HAVN Life Sciences has accumulated about 112.42 K in cash with (7.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing HAVN Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HAVN Life's stock is overvalued or undervalued compared to its peers.
- Examining HAVN Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HAVN Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HAVN Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HAVN Life's pink sheet. These opinions can provide insight into HAVN Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for HAVN Pink Sheet analysis
When running HAVN Life's price analysis, check to measure HAVN Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HAVN Life is operating at the current time. Most of HAVN Life's value examination focuses on studying past and present price action to predict the probability of HAVN Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HAVN Life's price. Additionally, you may evaluate how the addition of HAVN Life to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |